Changing pharma dynamics & the IT-Pharmacy
Tue, 7/07/09 – 16:59 | 2 Comments

Last week’s MM&M webcast titled “From Selling Pills to Selling Health Outcomes” was packed with thought provoking material. Joining the podcast were Daniel Hawkins (Clarion Healthcare Consulting), Dennis Urbaniak (Sanofi-Aventis) and Dan Rubin (inVentiv Patient …

Read the full story »
News

Alensa’s own news as well as the latest insights, opinions and gossip from all corners of the generics industry.

formulations

Information about the latest generics coming to market as well as our own product launches and products under development.

direct compression

Direct compression products could be a major contributor to the generics industry lowering the cost of medicines even further. Find out all about it here.

pellets

Pellets are quickly becoming a competitive segment of the generics industry. Learn about all the latest producers and innovations here.

api

The cornerstone of generics has never been more exciting than now, with companies all over the world rushing to successfully launch the latest molecules. Follow the latest API action here.

Home » Archive by Category

Articles in News

Industry shocker - Pfizer licenses from Aurobindo
Tuesday, 3 Mar, 2009 – 9:21 | No Comment
Industry shocker - Pfizer licenses from Aurobindo

You can’t imagine our surprise today when we saw that Pfizer has announced that it will license injectable and solid dosage forms from Aurobindo. We wrote about Pfizer’s new generics strategy on monday, but we …

Pfizer gives up the fight and joins generics bandwagon
Monday, 2 Mar, 2009 – 6:16 | One Comment
Pfizer gives up the fight and joins generics bandwagon

“If you can’t beat them, join them”. So goes the old saying that is proving more true day-by-day in the pharma industry.  A few years ago it would have been unthinkable that Pfizer, the world’s …

Big pharma grows a [heart] ?
Thursday, 19 Feb, 2009 – 6:04 | No Comment
Big pharma grows a [heart] ?

Two very positive announcements were made last week by Andrew Witty, chief executive of Galxo SmithKline. The first covers the price of medicines in developing nations which he said Glaxo would cap at no more …

Competition for biosimilars/biogenerics heating up
Wednesday, 21 Jan, 2009 – 10:26 | No Comment
Competition for biosimilars/biogenerics heating up

Even as patents on huge blockbuster drugs are still expiring, the smart generics companies have been preparing for some time for a future in which there are fewer and fewer syntehsized molecules to copy and …

Merckle’s Phoenix empire crumbling - UK operations for sale
Wednesday, 14 Jan, 2009 – 10:34 | No Comment
Merckle’s Phoenix empire crumbling - UK operations for sale

Following the death of Mr. Merckle, the sale of his empire continues at a swift pace. The Independent is reporting that Phoenix UK, with a turnover of €1.2bn and controlling 15 per cent of the …

Actavis to be sold
Monday, 12 Jan, 2009 – 5:07 | No Comment
Actavis to be sold

The first generics casualty of the financial crisis was Ratiopharm which is now being sold my the Merckle family to make up for their recent stock market losses. Now Actavis, the fifth largest generics company …

Adolf Merckle, owner of Ratiopharm, commits suicide
Tuesday, 6 Jan, 2009 – 20:44 | No Comment

We were shocked today to read that the owner of both Ratiopharm, one of Europe’s largest generics companies and Phoenix PharmaHandel, Europe’s 2nd largest drug distributor, has committed suicide as a result of having lost …

Merck latest big-pharma to join the generics bandwagon
Sunday, 14 Dec, 2008 – 8:11 | No Comment
Merck latest big-pharma to join the generics bandwagon

You know the big-pharma club is in trouble when most of its members are jumping ship from fighting against generics to producing generics themselves. Novartis, GSK, Sanofi and Daiichi are just a few examples of …

Generics equal to brand name drugs
Sunday, 14 Dec, 2008 – 7:43 | No Comment
Generics equal to brand name drugs

Despite all the positive awareness-building campaigns run by generics companies all over the world, there still remains a persistent stigma amongst patients and even some doctors that generic medicines are in some way different or …

Ratiopharm owner, Merckle, in financial trouble
Thursday, 4 Dec, 2008 – 3:01 | No Comment
Ratiopharm owner, Merckle, in financial trouble

Adolf Merckle, the owner of the privately held Ratiopharm, one of the worlds largest generics manufacturers, has gotten himself into a whole world of trouble over his attempts to short-sell Volkswagen shares recently. His play …